Characteristic | % Affected* |
Polyneuropathy | 100 |
Organomegaly | 45 to 85 |
| 23 to 78 |
| 22 to 70 |
| 26 to 74 |
| 11 to 25 |
Endocrinopathy | 67 to 89 |
| 55 to 89 |
| 16 to 33 |
| 5 to 20 |
| 12 to 18 |
| 3 to 36 |
| 9 to 67 |
Monoclonal plasma cell dyscrasia¶ | 100 |
| 24 to 55 |
Skin changes | 68 to 93 |
| 25 to 93 |
| 19 to 46 |
| 9 to 35 |
| 20 to 74 |
| 5 to 43 |
Papilledema | 29 to 64 |
Extravascular volume overload | 29 to 89 |
| 24 to 89 |
| 6 to 54 |
| 3 to 43 |
| 1 to 64 |
Bone lesions | 27 to 97 |
Thrombocytosis | 34 to 88 |
Polycythemia | 12 to 19 |
Clubbing | 5 to 49 |
Decreased DLCO | >15 |
Pulmonary hypertension | 36 |
Weight loss >10 lb | 37 to 41 |
Fatigue | 22 to 31 |
POEMS: polyneuropathy, organomegaly, endocrinopathy, M-protein, skin changes; DLCO: diffusing capacity of carbon monoxide.
* Percentages are based on the total number of patients in the series.
¶ In both the Takasuki and Nakanishi series, only 75% of patients had a documented plasma cell disorder, which defies the current definition for POEMS syndrome. As these are among the earliest series describing the syndrome, they are included.